4. Is either not on hydroxyurea at the Screening Visit and does not plan on receiving it during the course of the study or has received hydroxyurea for a minimum of 6 months and, except for safety reasons, will remain on the same weight-based dose of hydroxyurea from screening throughout the duration of the study;